Industry engagement & funding translational research for the ANU life sciences

Date & time

10am–12.30pm 26 April 2012

Location

The Finkel Lecture Theatre, The John Curtin School of Medical Research, Building 131, Garran Road, ANU

Contacts

 RSVP: Jennifer Eadie
 +61 2 6125 7741

Speakers include:

Daniel Grant (Pfizer) Head, External Research & Development Innovation (ERDI) - Australia, New Zealand, Singapore at Pfizer Australia. Previously, Director, Asia R&D Business Development, Australia, New Zealand, Singapore at Pfizer Australia.Chris Pugmire (Office of Commercialisation) Chris Pugmire is a Business Development Manager in the ANU Office of Commercialisation, and has 14 years’ experience of commercialising the outcomes of biomedical research. Chris joined the ANU in 2011 from Queen Mary Innovation Ltd (the commercialisation company of Queen Mary, University of London), where he was Director of Operations for six years. Previously he served for five years as Senior Business Development Manager in pharmaceuticals, healthcare and biotechnology for King’s College London.Anusha Subramaniam (Office of Commercialisation) Anusha Subramaniam has recently joined the Office of Commercialisation following from her previous role as Scientific Programs Manager at the Australian Phenomics Facility. Anusha is currently pursuing an MBA and has a background in immunology and genetics, with practical experience in the management of large-scale medical research projects.Karen Jackson (ANU Connect Ventures) Karen Jackson manages ANU Connect Ventures’ Discovery Translation Fund, a commercially focussed proof of concept fund. Karen has previously worked in sponsored research management for the ANU’s joint colleges, and as a business development manager in the Office of Commercialisation.

Updated:  19 October 2017/Responsible Officer:  Director, JCSMR/Page Contact:  Web Manager